Invivotek offers custom & standard pre-clinical services for NASH studies.  We help clients study mechanism of action, evaluate potential target genes and explore drug efficacy biomarkers.

Genesis Drug Discovery & Development (GD3) is a fully integrated CRO.

• Discovery Biology, Hit to Lead and Lead Optimization
• Synthetic Organic & Medicinal Chemistry (including IND and IP support)
• In vitro ADME
• Assay and Biomarker development
• Recombinant Protein Expression/Purification
• DMPK/in-vivo pharmacology & GLP Toxicology

Our clients span a wide range of therapeutic areas including oncology, ophthalmology, inflammation/autoimmunity, metabolic diseases, gene therapy, RNA targets and microbiome.